Work

Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Year: 2020

Type: erratum

Abstract: The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaa166

Authors: Jian Teng, Seyedali Hejazi, Lotte Hiddingh, Litia Carvalho, Mark de Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, Andrew S Chi, David P Noske, Pieter Wesseling, Thomas Wurdinger, Tracy T Batchelor, Bakhos A Tannous

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3127986114

Cites:

Cited by:

Related to: 10